Background Radioactive iodine 131 ( 131 I) therapy has long been used in the treatment of
differentiated thyroid cancers (DTC). While salivary and lacrimal glandular complications …

Background: Aim was to evaluate the dose distribution within the thyroid gland its association
with hypothyroidism in breast cancer (BC) patients receiving supraclavicular (SC) radiation …

Background The aim was to evaluate whether extended-field concurrent chemoradiation (EF-CCRT)
leads to results better than those obtained by standard whole-pelvis concurrent …

Background. Rosai-Dorfman Disease (RDD) is rare benign hematologic disorder of
histiocytes, which usually manifests as painless lymphadenopathy, fever, leukocytosis and …

Introduction Age is an important prognostic factor in differentiated thyroid cancer (DTC). Our
aim was to evaluate differences in clinicopathological features and treatment outcomes …

Hemangiopericytoma (HPC) is a rare tumor of uncertain malignant potential arising from
mesenchymal cells with pericytic differentiation. It accounts for 3-5% of soft tissue sarcomas and …

Background We aimed to investigate the patterns of failure (locoregional and distant
metastasis), associated factors, and treatment outcomes in nasopharyngeal carcinoma patients …

Background Radical cystectomy (RC) with or without neoadjuvant chemotherapy is the
standard treatment for muscle-invasive bladder cancers. However, the locoregional recurrence …

Background Papillary Microcarcinoma (PMC) of thyroid is a rare type of differentiated thyroid
cancer (DTC), which according to the World Health Organization measures 1.0 cm or less. …

Background Salivary ductal carcinoma (SDC) of parotid gland is a rare and aggressive entity;
accounting for 1–3 % of all malignant salivary gland tumors, 0.2 % of epithelial salivary …